Mariner LLC Buys 3,987 Shares of UnitedHealth Group Incorporated $UNH

Mariner LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 422,016 shares of the healthcare conglomerate’s stock after purchasing an additional 3,987 shares during the quarter. Mariner LLC’s holdings in UnitedHealth Group were worth $139,327,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in the business. Motiv8 Investments LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $67,000. Fieldview Capital Management LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $5,740,000. Financial Network Wealth Advisors LLC boosted its position in shares of UnitedHealth Group by 169.0% during the 4th quarter. Financial Network Wealth Advisors LLC now owns 156 shares of the healthcare conglomerate’s stock valued at $52,000 after acquiring an additional 98 shares in the last quarter. Focus Partners Wealth boosted its position in shares of UnitedHealth Group by 15.9% during the 4th quarter. Focus Partners Wealth now owns 245,168 shares of the healthcare conglomerate’s stock valued at $81,030,000 after acquiring an additional 33,606 shares in the last quarter. Finally, Fort Point Capital Partners LLC boosted its position in shares of UnitedHealth Group by 30.9% during the 4th quarter. Fort Point Capital Partners LLC now owns 2,118 shares of the healthcare conglomerate’s stock valued at $718,000 after acquiring an additional 500 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

UNH has been the subject of several analyst reports. Cantor Fitzgerald reissued an “overweight” rating on shares of UnitedHealth Group in a report on Thursday. Robert W. Baird lifted their price target on shares of UnitedHealth Group from $278.00 to $287.00 and gave the company an “underperform” rating in a report on Wednesday, April 22nd. UBS Group lifted their price target on shares of UnitedHealth Group from $410.00 to $460.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Raymond James Financial raised shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price target for the company in a report on Wednesday, April 1st. Finally, Royal Bank Of Canada lifted their price target on shares of UnitedHealth Group from $361.00 to $400.00 and gave the company an “outperform” rating in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $407.17.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UNH saw unusual bullish options activity, with investors buying 215,330 call contracts on Friday — about 120% above normal volume — a sign traders are positioning for more upside.
• Positive Sentiment: Analysts continue to turn more constructive: Erste Group recently nudged up FY2027 earnings estimates and kept a Buy rating, adding to the recent wave of positive commentary around the shares.
• Positive Sentiment: The company confirmed it will report second-quarter 2026 results on July 16, which keeps a near-term catalyst on the calendar and may be supporting investor interest as expectations build.
• Positive Sentiment: UnitedHealth also approved its quarterly dividend of $2.32 per share and rejected an independent board chair proposal at its annual meeting, reinforcing its capital-return profile and management control.
• Neutral Sentiment: Recent articles highlight UNH’s rebound toward new highs and its renewed appeal as a defensive healthcare and income stock, but these pieces are largely commentary rather than new company-specific developments.

UnitedHealth Group Stock Down 0.0%

Shares of NYSE:UNH opened at $408.34 on Monday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $415.98. The company has a 50 day moving average of $362.28 and a 200-day moving average of $326.91. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80. The stock has a market cap of $370.83 billion, a price-to-earnings ratio of 30.84, a P/E/G ratio of 1.64 and a beta of 0.64.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, topping the consensus estimate of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company had revenue of $111.65 billion during the quarter, compared to analysts’ expectations of $109.84 billion. During the same quarter in the previous year, the company earned $7.20 EPS. UnitedHealth Group’s revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 18.32 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th will be given a dividend of $2.32 per share. The ex-dividend date is Monday, June 15th. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s dividend payout ratio is presently 66.77%.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of the business’s stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the transaction, the chief executive officer owned 17,805 shares in the company, valued at approximately $6,320,775. The trade was a 4.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.28% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.